Terms: = Uterine cancer AND PHF6, BORJ, 84295, ENSG00000156531, MGC14797
4 results:
1. phf6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T-cell infiltration.
Wang X; Fang A; Peng Y; Yu J; Yu C; Xie J; Zheng Y; Song L; Li P; Li J; Kang X; Lin Y; Li W
J Cell Mol Med; 2023 Mar; 27(5):609-621. PubMed ID: 36756714
[TBL] [Abstract] [Full Text] [Related]
2. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/phf6 pathway.
Li J; Zhang Z; Hu Y; Wei Q; Shao X
Anticancer Drugs; 2022 Oct; 33(9):883-892. PubMed ID: 36136988
[TBL] [Abstract] [Full Text] [Related]
3. LINC00958/miR-3174/phf6 axis is responsible for triggering proliferation, migration and invasion of endometrial cancer.
Li QY; Shen JQ; Li JH; Dai DF; Saeed M; Li CX
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6853-6861. PubMed ID: 34859848
[TBL] [Abstract] [Full Text] [Related]
4. Notoginsenoside R1 induces DNA damage via phf6 protein to inhibit cervical carcinoma cell proliferation.
Cai T; Wu W; Guo L; Xia Y; Jiang X; Zhang L; Peng F; Ming P
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537816
[TBL] [Abstract] [Full Text] [Related]
